Table 2.
Comparative clinical and veterinary syndromes of zoonotic NTM.
| Host domain | Typical syndromes | Key NTM species | Zoonotic relevance | AMR concern |
|---|---|---|---|---|
| Humans | Chronic pulmonary disease, post-TB lung infection | M. abscessus,MAC | Shared environmental/animal sources | High;M. abscessuswitherm41-mediated macrolide resistance |
| Cutaneous/soft tissue (“fish tank granuloma”) | M. marinum, M. fortuitum, M. chelonae | Direct exposure via fish/aquaculture or contaminated wounds | Moderate; resistant isolates increasingly reported | |
| Disseminated infections (immunocompromised hosts) | M. intracellulare, M. kansasii | Often environmental, sometimes zoonotic link | Variable; multidrug resistance in select isolates | |
| Veterinary | Subclinical colonization; granulomatous lesions in cattle/swine | M. aviumsubsp.hominissuis,M. intracellulare | Farm-to-human transmission documented | Moderate; overlapping resistance with human isolates |
| Camel nasal/milk isolates in arid zones | M. fortuitum, M. intracellulare | Occupational and dairy-related zoonotic risk | Emerging; limited data but resistant strains reported | |
| Companion animal cutaneous/disseminated disease | M. fortuitum, M. chelonae, M. abscessus | Direct zoonotic exposure via pets | High; resistant strains comparable to human infections |
NTM: nontuberculous mycobacteria, AMR: Antimicrobial resistance, TB: Tuberculosis, MAC: Mycobacterium avium complex.